To Evaluate the Safety, Tolerability, Pharmacokinetics and the Effect of Food on the Hemay5259 Sustained-release Tablets in Healthy Subjects.

NCT07703904 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Hemay5259 group 1
DRUG: placebo group 1
DRUG: Hemay5259 group 2
DRUG: Placebo group 2

Sponsor

Hemay Pharmaceutical PTY. LTD.